Dawei Luo 13D and 13G filings for Vivos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-14 1:36 pm Purchase |
2025-07-08 | 13G | Vivos Therapeutics, Inc. VVOS |
Dawei Luo | 572,016 8.520% |
572,016 (New Position) |
Filing |